Search results for " reactions"

showing 10 items of 619 documents

Emergency Treatment of Anaphylactic Reactions in Air Rescue Missions: An Eight-Year Analysis of a German Rescue Helicopter Base.

2021

AbstractIntroduction:Anaphylactic reactions can lead to a life-threatening situation. In the event of anaphylaxis, rapid and targeted emergency treatment is indicated.Study Objective:The study sought to determine the emergency therapy administered for anaphylaxis in children and adults. Focus was placed on therapy with adrenaline. In addition, the study aimed to investigate demographic data, triggers, and hospitalization rates of the different severities of anaphylaxis.Methods:A retrospective analysis of anaphylactic reactions was conducted using data from prehospital emergency missions performed by the Air Rescue Dresden/Germany from 2008 through 2015 using the standardized application pro…

AdultMalemedicine.medical_specialtyAircraftEpinephrineAdverse outcomesmedicine.medical_treatmentEmergency NursingEmergency treatmentApplication protocolmedicineHumansInsect venomCardiopulmonary resuscitationChildAnaphylaxisEmergency TreatmentRetrospective Studiesbusiness.industryAnaphylactic reactionsmedicine.diseaseEpinephrineEmergency medicineEmergency MedicineFemalebusinessAnaphylaxismedicine.drugPrehospital and disaster medicine
researchProduct

Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.

2019

Background Hypersensitivity reactions to platinum salts (PS) (cisplatin [CI], carboplatin [CA], and oxaliplatin [OX]) can be severe and their incidence is increasing due to their widespread use in cancer treatment. Objective To determine the rate of cross-reactivity between PS and whether CI can be administered without prior allergy testing in patients with a history of CA or OX hypersensitivity. Methods From September 2002 to April 2016, patients with suspected immediate PS hypersensitivity were tested and cross-reactivity between the 3 PS was evaluated. We then studied patients who were given CI without desensitization after immediate hypersensitivity to other PS. Results A total of 155 p…

AdultMalemedicine.medical_specialtyAllergymedicine.medical_treatment[SDV]Life Sciences [q-bio]Antineoplastic AgentsPlatinum CompoundsCross ReactionsGastroenterologyCarboplatinDrug Hypersensitivity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineNeoplasmsImmunology and AllergyMedicineHumans030212 general & internal medicineDesensitization (medicine)AgedSkin TestsCisplatinAged 80 and overChemotherapybusiness.industryMiddle Agedmedicine.diseaseConfidence intervalCarboplatin3. Good healthOxaliplatinOxaliplatin030228 respiratory systemchemistryFemaleSaltsbusinessAnaphylaxismedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Res…

2010

Caspofungin at standard dose was evaluated as first-line monotherapy of mycologically documented probable/proven invasive aspergillosis (IA) (unmodified European Organisation for Research and Treatment of Cancer/Mycosis Study Group criteria) in allogeneic hematopoietic SCT patients. The primary efficacy end point was complete or partial response at end of caspofungin treatment. Response at week 12, survival and safety were additional end points. Enrollment was stopped prematurely because of low accrual, with 42 enrolled and 24 eligible, giving the study a power of 85%. Transplant was from unrelated donors in 16 patients; acute or chronic GVHD was present in 15. In all, 12 patients were neut…

AdultMalemedicine.medical_specialtyAntifungal AgentsDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentGraft vs Host DiseaseHematopoietic stem cell transplantationAspergillosischemistry.chemical_compoundEchinocandinsLipopeptidesYoung AdultPharmacotherapyCaspofunginInternal medicineMedicineAspergillosisHumansTransplantation HomologousaspergillosiscaspofunginAdverse effectSurvival rateAgedallogeneicTransplantationbusiness.industryHematopoietic Stem Cell Transplantationhematopoietic SCTHematologyMiddle Agedmedicine.diseaseSurgeryCalcineurinTransplantationEuropeSurvival RateTreatment OutcomechemistryDrug Therapy CombinationFemaleCaspofunginbusinessBone marrow transplantation
researchProduct

The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism

2019

Renal impairment, a source of chronic hypercoagulability[1][1] and inflammation,[2][2] is known to reduce the specificity of the D-dimer test in the diagnosis of venous thromboembolism (VTE).[3][3] This leads to many false positives in such patients and consequently to additional costs, as well as

AdultMalemedicine.medical_specialtyComputed Tomography AngiographyRenal functionSensitivity and SpecificityFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineText miningInternal medicineD-dimermedicineFalse positive paradoxHumansFalse Positive ReactionsProspective StudiesRenal InsufficiencyProspective cohort studyOnline Only ArticlesComputed tomography angiographyAgedProbabilityVenous Thrombosismedicine.diagnostic_testbusiness.industryHematologyVenous ThromboembolismMiddle AgedCardiologyFemalebusinessPulmonary EmbolismVenous thromboembolismAlgorithms030215 immunologyGlomerular Filtration RateHaematologica-the Hematology Journal
researchProduct

Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.

2020

Abstract Purpose The aim of this study is to present the treatment modalities and associated side effects in a Polish nation-wide ANCA-associated vasculitides (AAV) patients’ cohort. Materials and methods Retrospective analysis of patients diagnosed with AAV between 1990 and 2016, included in the POLVAS registry was performed. Standard descriptive statistic methods were used with an emphasis on the treatment modalities. Results There were 625 patients diagnosed with AAV included in this study: 417 cases of granulomatosis with polyangiitis (GPA; 66.7%), 106 cases of microscopic polyangiitis (MPA; 17.0%) and 102 cases of eosinophilic granulomatosis with polyangiitis (EGPA; 16.3%). The mean ag…

AdultMalemedicine.medical_specialtyCyclophosphamideDrug-Related Side Effects and Adverse ReactionsAzathioprineAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis03 medical and health sciences0302 clinical medicineMaintenance therapyInternal medicineAzathioprinemedicineHumansTreatment complications030212 general & internal medicineRegistriesAdverse effectCyclophosphamideGlucocorticoidsANCA associated vasculitisRetrospective Studiesbusiness.industryVasculitis registryGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival RateMethotrexate030220 oncology & carcinogenesisCohortRituximabDrug Therapy CombinationFemalePolandMicroscopic polyangiitisGranulomatosis with polyangiitisbusinessRituximabVasculitis treatmentImmunosuppressive Agentsmedicine.drugFollow-Up StudiesAdvances in medical sciences
researchProduct

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

2020

Abstract Background and Aims Although commonly used in inflammatory bowel disease [IBD], thiopurines frequently cause intolerance, and switching to a second thiopurine has only been reported in some small series. Ours aims in this study were to evaluate the safety of switching to a second thiopurine in a large cohort, and to assess the impact of age on tolerance. Methods Adult IBD patients from the ENEIDA registry, who were switched to a second thiopurine due to adverse events [excluding malignancies and infections], were identified. At the beginning of thiopurine treatment, patients were divided by age into two groups: 18–50 and over 60 years of age. The rate and concordance of adverse eve…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsConcordanceInflammatory bowel diseaseelderly03 medical and health sciences0302 clinical medicineinflammatory bowel diseaseInternal medicineAzathioprinemedicineHumans030212 general & internal medicinePractice Patterns Physicians'Adverse effectThiopurine elderly inflammatory bowel diseaseAgedThiopurine methyltransferasebiologyThiopurinebusiness.industryDrug SubstitutionMercaptopurineGastroenterologyAge FactorsGeneral MedicineOdds ratioDrug Tolerancemedicine.diseaseInflammatory Bowel DiseasesConfidence intervaldigestive system diseasesClinical PracticeSpainbiology.proteinAcute pancreatitis030211 gastroenterology & hepatologyFemaleRisk AdjustmentDrug MonitoringbusinessImmunosuppressive Agents
researchProduct

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

2018

Background Mepolizumab has demonstrated favorable safety and efficacy profiles in placebo-controlled trials of 12 months' duration or less; however, long-term data are lacking. Objective We sought to evaluate the long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma (SEA). Methods COLUMBA (Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects, NCT01691859 ) was an open-label extension study in patients with SEA previously enrolled in DREAM (Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma, NCT01000506 ). Patients received 100 mg of subcutaneous mepolizumab every 4 weeks plus standard of care until a protocol-def…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsExacerbationInjections Subcutaneous[SDV]Life Sciences [q-bio]ImmunologyEosinophilic asthmaAntibodies Monoclonal HumanizedPlacebos03 medical and health sciences0302 clinical medicineDouble-Blind MethodSurveys and QuestionnairesInternal medicineEosinophiliamedicineHumansImmunology and AllergyIn patientAnti-Asthmatic Agents030212 general & internal medicineAdverse effectRespiratory Tract InfectionsComputingMilieux_MISCELLANEOUSAsthmabusiness.industryMiddle Agedmedicine.diseaseAsthma3. Good healthEosinophils[SDV] Life Sciences [q-bio]Treatment Outcome030228 respiratory systemAsthma Control QuestionnaireBronchitisFemaleInterleukin-5businessMepolizumabmedicine.drug
researchProduct

Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital

2015

Drug-induced agranulocytosis is a rare haematological disorder considered as severe adverse drug reaction. Due to its low incidence, the number of studies are low and the variability of clinical features and presentation in hospitalized patients is rarely described. Awe performed an observational, transversal and retrospective study in the haematology and toxicology unit in a tertiary hospital located in Spain (Valencia) (1996–2010) in order to assess its incidence, the drugs involved, the management and outcomes of drug-induced agranulocytosis. Twenty-one cases of agranulocytosis were retrieved. All of them presented severe and symptomatic agranulocytosis (fever and infection). The most c…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsItraconazoleHealth Toxicology and Mutagenesis030204 cardiovascular system & hematologyToxicologyTertiary Care CentersLeukocyte Count03 medical and health sciences0302 clinical medicineSulfasalazineInternal medicineGranulocyte Colony-Stimulating FactormedicineHumans030212 general & internal medicineAgedAged 80 and overbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMetamizoleSpainAbsolute neutrophil countFemalebusinessCefuroximeAdverse drug reactionAgranulocytosismedicine.drugHuman & Experimental Toxicology
researchProduct

Is somatosensory amplification a risk factor for an increased report of side effects? Reference data from the German general population

2015

Abstract Objective The study investigates the association between somatosensory amplification and the reporting of side effects. It establishes a German version of the Somatosensory Amplification Scale and examines its psychometric properties in a representative sample of the German population. Methods Sample size was 2.469, with 51% taking any medication. Participants answered the Somatosensory Amplification Scale, Generic Assessment of Side Effects Scale, and indicated whether they were taking any medication and the type of medication. Correlational analysis and binary logistic regression were performed. Results When examining a subsample reporting both medication intake and general bodil…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsPsychometricsPsychometricsNoceboPopulationAudiologySomatosensory systemLogistic regressionRisk FactorsGermanymedicineHumansRisk factoreducationPsychiatryeducation.field_of_studySomatosensory amplificationSomatosensory CortexMiddle AgedPsychiatry and Mental healthClinical PsychologySample size determinationFemalePsychologyJournal of Psychosomatic Research
researchProduct

Ice water test in multiple sclerosis: A pilot trial.

2018

OBJECTIVES To investigate the significance of the ice water test in patients with multiple sclerosis and to evaluate a novel ice water test nomogram in a large patient cohort. METHODS A total of 201 ice water tests of patients with multiple sclerosis were retrospectively evaluated. Incontinence episodes in 24 h and sex were correlated with the ice water test. Furthermore, an ice water test nomogram was developed in order to categorize the detrusor overactivity in severity degrees. Descriptive statistics were carried out for population characteristics. Correlations of categorical variables were calculated by the χ2 -test. The independent t-test was carried out for correlations of continuous …

AdultMalemedicine.medical_specialtyMultiple SclerosisUrologyPopulation030232 urology & nephrologyUrologyPilot Projectsurologic and male genital diseases03 medical and health sciences0302 clinical medicinemedicineHumansUrinary Bladder NeurogeniceducationFalse Negative ReactionsNeurogenic bladder dysfunctionRetrospective Studieseducation.field_of_study030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryUrinary Bladder OveractiveMultiple sclerosisIceCystometryNomogramMiddle Agedmedicine.diseaseTest (assessment)NomogramsUrodynamicsOveractive bladderCohortLinear ModelsFemalebusinesshuman activitiesInternational journal of urology : official journal of the Japanese Urological Association
researchProduct